Le Lézard
Classified in: Health
Subjects: EXE, RCL, PSF

Advisory - Unauthorized "Smart Brain Formulations Serotonin Support" may pose serious health risks


OTTAWA, Dec. 1, 2017 /CNW/ -

Issue
Health Canada is advising Canadians that the unauthorized health product "Smart Brain Formulations Serotonin Support" may pose serious health risks. The product is labelled to contain lithium orotate, which is a prescription drug and should be used only under the supervision of a health care professional. Health Canada testing also found bacterial contamination with E. coli, which can cause serious health problems. The product was being offered for sale by the company Robert Lamberton Consulting, by email. The company currently does not hold a site licence or any product licences with Health Canada.

Who is affected

Affected products

What consumers should do

Background
Lithium is a prescription drug and is approved for treatment of manic episodes of manic-depressive illness. Common lithium side effects include increased thirst and urination, hand tremors and drowsiness. Severe dehydration has been reported. Intoxication can occur, especially when taken with other medications. Symptoms of intoxication can include vomiting, diarrhea, muscle twitches and lethargy. Patients should take lithium only after receiving a diagnosis and prescription from a health care professional. Otherwise, patients risk inappropriate treatment for their condition and harmful drug interactions or side effects.

E. coli are bacteria that live naturally in the intestines of some animals, and can be found in their feces. People infected with E. coli can have a wide range of symptoms. Common symptoms of E. coli can appear within one to ten days after contact with the bacteria, and include severe stomach cramps, profuse watery or bloody diarrhea, vomiting, nausea and headache. Young children aged 5 and under, older adults, and people with weakened immune systems are more likely to get sick and their symptoms may be more severe.

What Health Canada is doing
Health Canada is following up and will take further compliance and enforcement action as necessary. If additional retailers or distributors of these products are identified, Health Canada will take appropriate action and inform Canadians.

Related Links:

For more information
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.

To learn more about natural health products and other self-care products, visit Canada.ca/selfcare-products.

 

Également disponible en français

 

SOURCE Health Canada


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: